Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
GLP-1 drugs may reduce it, but they come with risks like muscle loss and weight regain
Functional testing showed a faster return to normal joint stability and range of motion
Competing Interests The authors declare the following competing interests: [Donghoon Kang and Chin-Ju Park] are listed as an inventor on a pending patent application related to A peptide inhibitor for senescent cell elimination, and a use thereof, filed by [Gwangju institute of science and technology] under application number KR10-2024-0086615
It appears to interact with central nervous system pathways involved in sleep regulation and stress hormone modulation
US$ 28.86
US$ 27.28
US$ 22.73
US$ 20.11
